How much does it cost to buy genuine Iressa in India 13301148797 Iressa price

Product Detailed Description
Jianjia website was recently named and exposed by the State Food and Drug Administration for illegally publishing false drug information and selling drugs. One of the websites was selling and promoting an anti-cancer drug Iressa purchased from India. The reporter’s investigation revealed that many anti-cancer drugs with good efficacy, including Iressa, have provided space for overseas purchasing due to the high price of officially imported drugs.
In recent years, a large number of overseas drug purchasing information has emerged in the chaotic online sales market, and it is difficult to distinguish whether it is true or false. Experts remind cancer patients that every step of treatment is very critical and they must race against the ever-changing cancer cells. There is no room for sloppiness. If they buy counterfeit drugs, they will pay the price of their lives. Therefore, we remind you that the risks of purchasing drugs overseas on the Internet are high. If you are not careful, you may become a step-by-step surprise.
The low price of drugs purchased in the market attracts patients
The reporter learned that not only the Iressa network but also overseas purchasing websites, online stores and transfer information for cancer drugs such as Gleevecterol and Keherceptin. There is currently no domestic production of these drugs and they rely entirely on imports from pharmaceutical companies in Europe and the United States. However, these drugs are quite expensive in the domestic market.
Gleevec is a patented drug of Novartis of Switzerland. It is used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors. It is currently the best drug to treat leukemia in the world. Each box costs about RMB 1,000. The average patient spends about RMB 10,000 per month. The price of each box of Luokai is about RMB 1. The latest oral targeted therapy drug for non-small cell lung cancer is currently clinically studied and proven to be the only targeted therapy drug that can significantly prolong the survival of lung cancer patients. Herceptin has a significant effect in treating advanced breast cancer and the price is about RMB 1. Zhiyuan.
My father took Iressa for half a year and spent more than 100,000 yuan on it. I really can’t afford it. We all know that Herceptin is effective in treating advanced breast cancer, but the high self-pay price is too high for me to bear. Do I have to wait for death? ? Such helpless complaints can be seen everywhere on the Internet. Along with this, drug purchasing information appeared on a website called XinTong, which provided information on the supply of Peruvian Tarceva with a price tag for a box of Yuanyuanxin Pharmaceuticals, which specializes in selling imported drugs. The online claim is that it specializes in purchasing Herceptin from the United States at a price of RMB/unit. There is also the Indian Desen Purchasing Online, which has been exposed and shut down by the State Food and Drug Administration. It has long been selling Iressa purchasing prices via direct mail from India.
Experts emphasize that generic drugs are low-cost and low-price
Why is there such a big price difference between the Indian version of anti-cancer drugs and the original imported drugs sold in China? Luo Rongcheng, vice president of Nanfang Hospital, explained that the main reason was patent issues. The R&D of an anti-tumor drug requires a large investment in the early stage and requires rigorous clinical research plus tariffs, so the price of the drug cannot be reduced, and these drugs are also protected by patent rights. However, if a public health incident like SARS occurs, special measures can be taken. In 2016, the WTO General Council passed an executive resolution in paragraph 6 of the Doha Declaration, which clarified that developing member states and least developed member states may implement a compulsory licensing system to produce, sell and use patented medicines without the consent of the patentee when a public health crisis occurs. my country's newly implemented Compulsory Licensing Measures for Patent Exploitation also stipulate that in the event of a national emergency or extraordinary situation, the relevant competent authorities of the State Council may recommend that the State Intellectual Property Office grant a compulsory license to the units designated by it that meet the conditions for implementation.
Yu Mingde, president of the China Pharmaceutical Enterprise Management Association, believes that cancer does not meet the conditions for forced imitation due to its limited scope and harm. But India is exactly the exception. India is a major country in the world of generic drugs. Its current patent law clarifies the product patent of the drug itself, but stipulates that if it is unable to obtain a product, cannot afford it, or cannot provide it appropriately, local companies can apply to the Intellectual Property Office of India for a compulsory license. Domestic companies that obtain a compulsory license Companies can produce and sell generic products but must pay royalties to the company that holds the patent. This is why anti-cancer drugs appear in India that are much cheaper than in China.
Efficacy: The Indian version of anti-cancer drugs cannot guarantee the efficacy
The biggest problem for patients with the Indian version of anti-cancer drugs is whether the efficacy is guaranteed. Zhi Xiuyi, director of the Lung Cancer Center of Capital Medical University, expressed concern about the quality of the cheap generic version of Iressa. We discovered early on in our clinical work that there is an Indian version of Iressa. He encountered some patients who hid it from their doctors because of the price. Use the so-called cheaper Iressa from the underworld. Zhi Xiuyi said that there was a patient who originally took the regular Iressa but switched to the Indian version due to financial reasons, and his condition worsened and he came to the doctor. Some doctors also expressed objections. Luo Rongcheng cautiously said that without a large-sample comparative survey, he cannot draw a conclusion on the efficacy of the so-called Indian version of Iressa or the Indian version of other cancer drugs. Many doctors in the pharmacy department are not sure about this. It is legal for patients to bring drugs from overseas to China for self-administration. However, since we cannot have clinical trial data on these drugs, we do not know the efficacy of these drugs and cannot control the dosage, so we seek medical advice. We all advise patients to stop these medications and the hospital will refill them.
The main concern is that patients will buy counterfeit Iressa, Luo Rongcheng said. As far as I know, there are manufacturers in China that specialize in making counterfeit patented drugs, which is absolutely dangerous. Once patients take it, it will affect regular treatment, delay the condition, and even worsen the condition. Zhi Xiuyi also pointed out that a considerable number of illegal people are engaged in selling the Indian version of Iressa. I don’t know if there will be a Cambodian and Vietnamese version of Iressa one day. He expressed obvious concern about the low-priced Iressa appearing through informal channels. In addition, Zhi Xiuyi also said that the current domestic genuine Iressa is priced by relevant national departments. With the widespread clinical use, the price will definitely drop to a certain extent. As an individual, Zhi Xiuyi does not want patients to experience good effects after taking the genuine medicine. Due to economic factors, the drug was changed to a so-called lower-priced version.
Imported drugs that have not been approved by the Food and Drug Administration are counterfeit drugs
The State Food and Drug Administration pointed out that according to our country’s laws, all smuggled drugs that have not been formally registered and marketed in our country are considered counterfeit drugs. Luo Rongcheng said that if something goes wrong with the medicines that patients purchase through informal channels, it is difficult for them to have laws to protect the rights of patients. The cost of defending rights overseas will be very high, and as the patient's attending doctor, he is not legally responsible because it is the result of the patient's own purchase of medicines. . Therefore, patients are reminded to be cautious when purchasing overseas.
In addition, the head of publicity in China of AstraZeneca Pharmaceutical Co., Ltd. told reporters that there are two possibilities for the Indian Iressa flowing into the country: one is an Indian generic drug and the other is a fake drug with no origin. However, according to relevant national regulations, even if Iressa, which is officially produced in India, has not undergone clinical verification and any quality inspection in China, has not obtained import approval from the State Food and Drug Administration, and has flowed into China through illegal channels, it is considered a fake drug